Alteration of islet function in type 2 diabetic patients with cholecystectomy

被引:0
|
作者
Zhang, Liyi [1 ]
Chang, Baocheng [1 ]
Shan, Chunyan [1 ]
Kong, Yan [1 ]
Shi, Zhenzhen [1 ]
Gao, Zhongai [1 ]
Yang, Juhong [1 ]
机构
[1] Tianjin Med Univ, Dept Diabet Nephrol, Metab Dis Hosp, Key Lab,Minist Hlth Hormones & Dev, Tianjin, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1069058
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Alteration of Pharmacokinetics of Grepafloxacin in Type 2 Diabetic Rats
    Watanabe, Meguho
    Kobayashi, Masaki
    Ogura, Jiro
    Takahashi, Natsuko
    Yamaguchi, Hiroaki
    Iseki, Ken
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (01): : 25 - 33
  • [42] Effect of troglitazone on endothelial function in type 2 diabetic patients
    Takase, H
    Hakamata, M
    Toriyama, T
    Hayashi, K
    Gotoa, T
    Sato, K
    Ueda, R
    Dohi, Y
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2002, 52 (01): : 34 - 38
  • [43] Compromised arterial function in human type 2 diabetic patients
    Okon, EB
    Chung, AWY
    Rauniyar, P
    Padilla, E
    Tejerina, T
    McManus, BM
    Luo, HL
    van Breemen, C
    DIABETES, 2005, 54 (08) : 2415 - 2423
  • [44] Thiazolidinediones improve β-cell function in type 2 diabetic patients
    Gastaldelli, Amalia
    Ferrannini, Ele
    Miyazaki, Yoshinori
    Matsuda, Masafumi
    Mari, Andrea
    DeFronzo, Ralph A.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2007, 292 (03): : E871 - E883
  • [45] THYROID ANTIBODIES, ISLET CELL ANTIBODIES AND ISLET CELL-FUNCTION IN DIABETIC-PATIENTS
    ZEIDLER, A
    NICOLOFF, JT
    HALL, TD
    STEIN, RB
    FRASIER, SD
    CLINICAL RESEARCH, 1979, 27 (01): : A89 - A89
  • [46] Islet cell function in type 1 and type 2 diabetes
    Hao, W
    Palmer, JP
    JOURNAL OF CLINICAL LIGAND ASSAY, 1998, 21 (03): : 309 - 317
  • [47] Explore the Effect and Target of Liraglutide on Islet Function in Type 2 Diabetic Rats by miRNA Omics Technology
    Guo, Qiuyue
    Xu, Yunsheng
    Li, Jie
    An, Wenrong
    Luo, Dan
    Huang, Chengcheng
    Huang, Yanqin
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 3795 - 3807
  • [48] Prevalence of metabolic syndrome in type 2 diabetic families and the relations with the function of islet β-cell and insulin resistance
    Wan, Qing
    Bai, Yan
    Li, Chunyan
    Zhao, Yuehua
    Du, Xinli
    Feng, Shiliang
    DIABETES, 2006, 55 : A563 - A564
  • [49] Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue
    Wu, Jiaying
    Li, Tuo
    Guo, Meng
    Ji, Junsong
    Meng, Xiaoxi
    Fu, Tianlong
    Nie, Tengfei
    Wei, Tongkun
    Zhou, Ying
    Dong, Weihua
    Zhang, Ming
    Shi, Yongquan
    Cheng, Xin
    Yin, Hao
    Mou, Xiaoyu
    Feng, Yifan
    Xu, Xiaoliang
    Dong, Junfeng
    He, Duowen
    Zhou, Yuanyu
    Zhou, Xue
    Wang, Xueqi
    Shen, Feng
    Wang, Yue
    Ding, Guoshan
    Fu, Zhiren
    CELL DISCOVERY, 2024, 10 (01)
  • [50] Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy
    Rossing, P
    Rossing, K
    Gaede, PH
    Pedersen, OB
    Parving, HH
    DIABETOLOGIA, 2005, 48 : A75 - A75